Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamphetamine for obesity with obstructive sleep apnoea
ACTRN12614000654651Phase 4Active, not recruiting
- Sponsor
- Nepean Blue Mountains Local Health District
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in obesity and obstructive sleep apnea hypopnea syndrome (OSAHS) comparing Dexamphetamine with Placebo (2 arms). Primary endpoints: Change in body weight from baseline, Change in apnoea-hypopnoea index from baseline and 1 more. Started Jun 2015; status: active, not recruiting.
02
Drugs
dextroamphetamine
03
Conditions
obesityobstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ACTRN12614000654651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000654651.